牛叉诊股

[{"date":"2026.01.22","stock":"-0.29","trade":"-0.59","ind":"0.50"},{"date":"2026.01.21","stock":"0.29","trade":"0.19","ind":"0.70"},{"date":"2026.01.20","stock":"-0.68","trade":"-0.83","ind":"-0.97"},{"date":"2026.01.19","stock":"-0.48","trade":"0.05","ind":"0.09"},{"date":"2026.01.16","stock":"-1.52","trade":"-0.86","ind":"-0.18"},{"date":"2026.01.15","stock":"-1.50","trade":"-1.14","ind":"0.41"},{"date":"2026.01.14","stock":"-2.02","trade":"-0.57","ind":"0.56"},{"date":"2026.01.13","stock":"4.62","trade":"2.27","ind":"-1.37"},{"date":"2026.01.12","stock":"1.17","trade":"0.29","ind":"1.75"},{"date":"2026.01.09","stock":"0.98","trade":"2.11","ind":"1.15"},{"date":"2026.01.08","stock":"1.60","trade":"0.71","ind":"-0.51"},{"date":"2026.01.07","stock":"-0.10","trade":"1.05","ind":"0.06"},{"date":"2026.01.06","stock":"0.00","trade":"0.42","ind":"1.40"},{"date":"2026.01.05","stock":"4.81","trade":"3.31","ind":"2.24"},{"date":"2025.12.31","stock":"-0.52","trade":"-0.13","ind":"-0.58"},{"date":"2025.12.30","stock":"0.00","trade":"-0.53","ind":"0.49"},{"date":"2025.12.29","stock":"-1.54","trade":"-1.04","ind":"-0.49"},{"date":"2025.12.26","stock":"-0.61","trade":"-0.26","ind":"0.54"},{"date":"2025.12.25","stock":"0.00","trade":"0.22","ind":"0.33"},{"date":"2025.12.24","stock":"0.20","trade":"0.78","ind":"0.88"},{"date":"2025.12.23","stock":"-0.41","trade":"-0.53","ind":"0.27"}]

安科生物,深证成指,生物制品指数

压力支撑

该股压力位为10.22元，支撑位为10.16元。

[{"text":"\u538b\u529b\u4f4d","value":"10.22","date":1769011200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.16","date":1769011200,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：1.4资金面打败了1%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：01月22日 16:45

机构今日流向(万元)	-1928.88	机构5日流向(万元)	-9246.27
机构10日流向(万元)	-14572.91	机构20日流向(万元)	-12597.27

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少2009.38万股，其中基金净减仓19家，主力净减仓1家，请投资者中长期谨慎为宜。

截止2025-06-30，共175家主力机构（基金173家，一般法人2家），持仓量总计13369万股，占流通A股10.94%
其中，基金持仓与2024-12-31相比：
增仓：21家，增持 64.45万股
减仓：40家，减持 665.35万股
新出现在主力名单中：110家，持有5562.42万股
从主力名单中消失：111家，原持有7701.51万股

消息面诊股

诊断结果：5.5消息面打败了33%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	任期届满后离任	2025-12-18
一般消息	股东大会	临时股东大会	2025-11-26
一般消息	重大事项	关联交易	2025-11-11
一般消息	分红转增	不分配不转增	2025-08-22
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
利好	分红转增	10派1.5元(含税)	2025-03-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：6.3行业面打败了70%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.01.22","price":"0.50","value":"-0.59"},{"date":"2026.01.21","price":"0.70","value":"0.19"},{"date":"2026.01.20","price":"-0.97","value":"-0.83"},{"date":"2026.01.19","price":"0.09","value":"0.05"},{"date":"2026.01.16","price":"-0.18","value":"-0.86"},{"date":"2026.01.15","price":"0.41","value":"-1.14"},{"date":"2026.01.14","price":"0.56","value":"-0.57"},{"date":"2026.01.13","price":"-1.37","value":"2.27"},{"date":"2026.01.12","price":"1.75","value":"0.29"},{"date":"2026.01.09","price":"1.15","value":"2.11"},{"date":"2026.01.08","price":"-0.51","value":"0.71"},{"date":"2026.01.07","price":"0.06","value":"1.05"},{"date":"2026.01.06","price":"1.40","value":"0.42"},{"date":"2026.01.05","price":"2.24","value":"3.31"},{"date":"2025.12.31","price":"-0.58","value":"-0.13"},{"date":"2025.12.30","price":"0.49","value":"-0.53"},{"date":"2025.12.29","price":"-0.49","value":"-1.04"},{"date":"2025.12.26","price":"0.54","value":"-0.26"},{"date":"2025.12.25","price":"0.33","value":"0.22"},{"date":"2025.12.24","price":"0.88","value":"0.78"},{"date":"2025.12.23","price":"0.27","value":"-0.53"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	安科生物	600.00%	0.00%	4.9分
2	沃森生物	29.86%	2.26%	5.4分
3	万泽股份	24.79%	25.07%	6.8分
4	荣昌生物	24.03%	-5.29%	5.5分
5	百普赛斯	19.80%	3.50%	5.9分
6	艾迪药业	18.53%	-13.39%	5.7分
7	近岸蛋白	18.16%	2.37%	5.5分
8	东宝生物	17.33%	0.93%	6.2分
9	赛伦生物	14.60%	4.26%	5.9分
10	禾元生物	12.07%	-4.98%	4.9分
11	-	11.02%	-5.79%	分
12	诺唯赞	10.28%	-2.83%	5.9分
13	优宁维	9.73%	0.31%	5.7分
14	智翔金泰	9.65%	-4.97%	4.4分
15	昊帆生物	9.48%	-0.20%	5.2分
16	辽宁成大	8.22%	1.39%	6.1分
17	百克生物	7.82%	0.99%	4.3分
18	博晖创新	6.55%	0.45%	5.7分
19	康希诺	6.43%	-3.56%	5.3分
20	派林生物	6.33%	-2.86%	4.4分
21	赛升药业	6.28%	-1.39%	4.8分
22	通化东宝	5.75%	3.15%	6.6分
23	-	5.16%	-5.32%	分
24	*ST双成	5.00%	0.00%	6.6分
25	甘李药业	4.74%	-2.84%	5.6分
26	康辰药业	4.44%	-0.12%	5.0分
27	西藏药业	4.13%	-0.66%	5.4分
28	长春高新	4.07%	-2.60%	5.1分
29	康弘药业	3.96%	-4.36%	4.4分
30	神州细胞	3.64%	-4.13%	4.6分
31	天坛生物	3.35%	-2.40%	4.3分
32	科兴制药	2.72%	-2.89%	5.4分
33	康泰生物	2.59%	-3.50%	4.8分
34	成大生物	2.24%	-1.45%	5.0分
35	百奥泰	2.18%	-3.18%	4.7分
36	卫光生物	2.05%	1.78%	5.1分
37	我武生物	1.77%	-3.15%	4.7分
38	华兰生物	1.38%	-0.52%	5.0分
39	博雅生物	0.79%	-1.20%	4.7分
40	君实生物	0.57%	-6.33%	3.7分
41	康华生物	0.24%	-1.32%	5.0分
42	迈威生物	-0.08%	-5.81%	3.5分
43	华兰疫苗	-0.16%	-3.16%	4.2分
44	欧林生物	-0.43%	-12.74%	4.2分
45	上海莱士	-0.47%	-1.25%	3.9分
46	金迪克	-3.61%	-2.33%	4.3分
47	三生国健	-4.59%	-0.16%	4.6分
48	ST未名	-7.24%	-5.68%	4.1分
49	-	-8.96%	-4.40%	分
50	特宝生物	-9.53%	0.30%	4.7分
51	诺诚健华	-9.93%	-9.31%	4.2分
52	凯因科技	-11.17%	-15.60%	4.7分
53	义翘神州	-	-3.03%	4.2分
54	智飞生物	-	-13.99%	3.6分
55	*ST四环	-	10.12%	6.6分

<上一页 1 2 3 4 5...10 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.1基本面打败了90%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（77.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 5/72 ， 24/72。

[{"date":"2025-09-30","value":"13.30","vol":"-9.78"},{"date":"2025-06-30","value":"9.06","vol":"-0.61"},{"date":"2025-03-31","value":"5.09","vol":"0.46"},{"date":"2024-12-31","value":"17.98","vol":"-0.68"},{"date":"2024-09-30","value":"15.37","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	13.30	9.06	5.09	17.98	15.37
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"75.97","vol":"67.61"},{"date":"2025-06-30","value":"76.45","vol":"68.28"},{"date":"2025-03-31","value":"76.96","vol":"68.43"},{"date":"2024-12-31","value":"77.39","vol":"69.85"},{"date":"2024-09-30","value":"77.75","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	75.97	76.45	76.96	77.39	77.75
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 29/72 ， 28/72。

[{"date":"2025-09-30","value":"2.15","vol":"45.25"},{"date":"2025-06-30","value":"-0.51","vol":"6902.04"},{"date":"2025-03-31","value":"-4.17","vol":"6125.27"},{"date":"2024-12-31","value":"-11.51","vol":"47.35"},{"date":"2024-09-30","value":"-4.95","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	2.15	-0.51	-4.17	-11.51	-4.95
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-6.48","vol":"44.80"},{"date":"2025-06-30","value":"-11.92","vol":"5.44"},{"date":"2025-03-31","value":"-4.02","vol":"-8.46"},{"date":"2024-12-31","value":"-16.56","vol":"-9.81"},{"date":"2024-09-30","value":"-9.89","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-6.48	-11.92	-4.02	-16.56	-9.89
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，居行业前列，两项指标的行业排名分别为 5/72 ， 6/72。

[{"date":"2025-09-30","value":"0.38","vol":"0.22"},{"date":"2025-06-30","value":"0.26","vol":"0.14"},{"date":"2025-03-31","value":"0.12","vol":"0.06"},{"date":"2024-12-31","value":"0.50","vol":"0.29"},{"date":"2024-09-30","value":"0.39","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.38	0.26	0.12	0.50	0.39
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.64","vol":"0.92"},{"date":"2025-06-30","value":"1.05","vol":"0.56"},{"date":"2025-03-31","value":"0.49","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.17"},{"date":"2024-09-30","value":"1.58","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.64	1.05	0.49	2.15	1.58
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"35.71","vol":"1.84"},{"date":"2025-06-30","value":"18.27","vol":"-1377.61"},{"date":"2025-03-31","value":"31.05","vol":"-46.99"},{"date":"2024-12-31","value":"43.02","vol":"-11.33"},{"date":"2024-09-30","value":"34.56","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	35.71	18.27	31.05	43.02	34.56
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.52","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.94","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.52	-	0.94	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 30/72 ， 32/72。

[{"date":"2025-09-30","value":"3.78","vol":"6.00"},{"date":"2025-06-30","value":"3.36","vol":"6.64"},{"date":"2025-03-31","value":"3.07","vol":"7.75"},{"date":"2024-12-31","value":"3.41","vol":"6.72"},{"date":"2024-09-30","value":"3.20","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	3.78	3.36	3.07	3.41	3.20
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"3.05","vol":"4.84"},{"date":"2025-06-30","value":"2.63","vol":"5.30"},{"date":"2025-03-31","value":"2.61","vol":"6.35"},{"date":"2024-12-31","value":"2.95","vol":"5.40"},{"date":"2024-09-30","value":"2.70","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	3.05	2.63	2.61	2.95	2.70
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 33/72 ， 33/72。

[{"date":"2025-09-30","value":"14.81","vol":"28.18"},{"date":"2025-06-30","value":"15.83","vol":"26.73"},{"date":"2025-03-31","value":"16.52","vol":"26.03"},{"date":"2024-12-31","value":"16.27","vol":"25.81"},{"date":"2024-09-30","value":"17.20","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	14.81	15.83	16.52	16.27	17.20
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.18","vol":"0.58"},{"date":"2025-06-30","value":"0.20","vol":"1.11"},{"date":"2025-03-31","value":"0.21","vol":"0.78"},{"date":"2024-12-31","value":"0.20","vol":"0.87"},{"date":"2024-09-30","value":"0.22","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.18	0.20	0.21	0.20	0.22
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华安证券	2025-11-17	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"2.07","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.86","blueLineValue":"0.47","type":"YC"}]

[安科生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]